Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer …

AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti… - Jama, 2017 - jamanetwork.com
Importance Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic
drugs provides clinical benefit to patients with advanced or metastatic colorectal cancer, but …
被引用次数：863 相关文章

Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer …

AP Venook, D Niedzwiecki, HJ Lenz… - JAMA-Journal of …, 2017 - scholars.northwestern.edu
IMPORTANCE Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic
drugs provides clinical benefit to patients with advanced or metastatic colorectal cancer, but …

Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer …

AP Venook, D Niedzwiecki, HJ Lenz… - JAMA-Journal of …, 2017 - researchwithrutgers.com
IMPORTANCE Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic
drugs provides clinical benefit to patients with advanced or metastatic colorectal cancer, but …
[PDF] core.ac.uk

[PDF][PDF] Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic …

CD Venook - JAMA, 2017 - core.ac.uk
IMPORTANCE—Combining biologic monoclonal antibodies with chemotherapeutic
cytotoxic drugs provides clinical benefit to patients with advanced or metastatic colorectal …

Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer …

AP Venook, D Niedzwiecki, HJ Lenz… - JAMA-Journal of the …, 2017 - ohsu.elsevierpure.com
IMPORTANCE Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic
drugs provides clinical benefit to patients with advanced or metastatic colorectal cancer, but …

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal …

AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti… - JAMA, 2017 - escholarship.org
ImportanceCombining biologic monoclonal antibodies with chemotherapeutic cytotoxic
drugs provides clinical benefit to patients with advanced or metastatic colorectal cancer, but …
[HTML] nih.gov

[HTML][HTML] Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic …

AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti… - JAMA, 2017 - ncbi.nlm.nih.gov
OBJECTIVE To determine if the addition of cetuximab vsbevacizumab to the combination of
leucovorin, fluorouracil, and oxaliplatin (mFOLFOX6) regimen or the combination of …

Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer …

AP Venook, D Niedzwiecki… - JAMA-Journal of …, 2017 - ohiostate.elsevierpure.com
IMPORTANCE Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic
drugs provides clinical benefit to patients with advanced or metastatic colorectal cancer, but …

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal …

AP Venook, D Niedzwiecki, HJ Lenz… - JAMA-The Journal of …, 2017 - cdr.lib.unc.edu
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall
Survival in Patients With KRAS Wild-Type Adv Page 1 Effect of First-Line Chemotherapy …

[引用][C] Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic …

AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti… - JAMA, 2017 - cir.nii.ac.jp
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall
Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer …